GE Healthcare announces a strategic partnership with Finesse Solutions to develop a WAVE Bioreactor control package
April 2, 2008 ─ GE Healthcare has announced a strategic partnership with Finesse Solutions LLC to develop a WAVE BioreactorTM control package based on the Finesse TruLogicTM controller with TruBioTM SCADA.
The TruBio Bioprocess Control Operating System is an open, fully configurable, software solution, developed with GAMP4 methods and validated for cGMP applications. TruBio software is supplied with algorithms for controlling WAVE Bioreactor parameters such as pH, dissolved oxygen, temperature, rocking speed, pressure, aeration, and weight, as well as supporting redundant sensor loops for pH or dissolved oxygen. TruBio software has been optimized for DeltaV-enabled TruLogic Controllers.
Finesse highlighted this collaboration at Interphex by displaying a WAVE BioreactorTM communicating with their TruBio software.
For more information on the various control platforms Finesse offers, visit their website: www.finesse.com
For more information on the WAVE BioreactorTM system and supporting single-use bioprocessing tools, visit the GE Healthcare WAVE Products website: www.gelifesciences.com/wave